Navigation Links
FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database
Date:8/26/2014

NEW YORK and LONDON, August 26, 2014 /PRNewswire/ --


 

FDNA Inc. (http://www.fdna.com) and London Medical Databases Ltd. (http://www.lmdatabases.com) announced today that they have partnered to offer, for the first time, online access to the award winning database exclusively through FDNA's solutions.

FDNA, developer of the Facial Dysmorphology Novel Analysis technology, will fully integrate LMD's award-winning collection into Face2Gene[TM], the only available dysmorphology genetic search and reference solution, using facial analysis technology. Combining the power of Face2Gene's advanced facial dysmorphology analysis and phenotype search algorithms and of LMD's comprehensive collection of images and medical reference into one, simple to use and accessible solution provides a robust solution for the genetics professionals' community.

"We are delighted to have partnered with FDNA. FDNA's unique technology, innovative solutions and strong commitment to the community of genetics professionals made them a perfect partner to carry our life's work of curation into the new era of dysmorphology," said Dr. Michael Baraitser, Co-Author of LMD. "Making LMD available online is a long awaited need. FDNA's innovative technology adds unparalleled value to our existing and new customers. This unique combination allows users to access the most updated LMD version anytime, anywhere and easily search for the most relevant references," added Dr. Baraitser.

LMD has become, over the past 20 years, the gold-standard dysmorphology reference for genetics professionals. The databases include a superb collection of over 20,000 images, which show dysmorphic features and other relevant medical images associated with a multitude of genetic disorders.

"Integrating LMD into Face2Gene combines the world's first and only available computer-aided dysmorphology analysis solution with the most reputable dysmorphology database collection. The partnership places unparalleled power and convenience in the hands of thousands of medical professionals," said Dekel Gelbman, CEO of FDNA Inc. "We are honored to partner with LMD. This partnership further underscores our commitment to the genetics community. We plan to continue enhancing Face2Gene in many ways, making it better and more useful," added Mr. Gelbman.

Under this partnership, Dr. Baraitser will join FDNA's scientific advisory board headed by Dr. Michael R. Hayden and comprised of some of key opinion leaders in genetics, Including Dr. David A. Chitayat, Prof. Jill Clayton-Smith, Dr. Cynthia J.R. Curry, Prof. Dian Donnai, Dr. Sofia Douzgou, Dr. Karen W. Gripp, Dr. Judith G. Hall, Prof. Arnold Munnich, Prof. Motti Shohat, and Prof. Lina Vanagaite-Basel.

About LMD:

Co-founded by Prof. Robin Winters and Dr. Michael Baraitser and edited by both until the premature death of Prof. Winter in 2003, LMD produces award-winning databases in the medical genetics field. With a worldwide user base built up over 20 years and drawing on the extensive clinical experience of their authors, the databases have become invaluable reference and diagnostic tools for the clinician. Currently the LMD series comprises: Winter-Baraitser Dysmorphology Database (WBDD), Baraitser-Winter Neurogenetics Database (BWDB) and London Ophthalmic Genetics Database (GENEEYE).  

About FDNA:

Face2Gene is a genetic search and reference solution powered by FDNA® (Facial Dysmorphology Novel Analysis) technology. Face2Gene facilitates detection of facial dysmorphic features and recognizable patterns of human malformations to present comprehensive and up-to-date genetic references. Face2Gene aids and empowers in accelerating and increasing confidence in the research and investigation of genetic syndromes. The solution leverages advanced algorithms and the cumulative experience of hundreds of genetics professionals and tens of thousands of analyzed cases. Face2Gene technology improves over time, referencing comprehensive phenotype databases in real-time.

Contact: FDNA Inc.
Yaron Front, V.P. Marketing
+1-(347)-305-0076
yaron.front@fdna.com


'/>"/>
SOURCE FDNA Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
2. Fuse Science Partners With GNC To Open National Distribution Of EnerJel™
3. Medical Guardian Announces Social Media Partnership with Senior Citizen Charity
4. The ALS Therapy Development Institute Partners with Neurotune to Investigate Potential Treatments for Motor Neuron Disease
5. ClearCanvas Partners With DPR to Offer CaseReader™, an Integrated Technology Structured Reporting Solution for Medical Imaging Professionals
6. VitaTech Adds New Capacity for Production and Customer Interface, Attributes Growth to Strategic Customer Partnerships
7. Bayer Partnership Delivers Industry-First Dose Management Offering
8. HUYA Bioscience International Engages In Partnership With Zhuhai Sanzao Science and Technology Industrial Park
9. Profil Institute Partners with Florida Hospital to Establish East Coast Center for Clinical Metabolic Research
10. Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
11. UBM Canon, the Global MedTech Authority, Partners with the World Medical Device Organization, WMDO, to Provide Medical Device Companies with Industry-Related Online Training Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2016)... PUNE, India , May 30, 2016 /PRNewswire/ ... research report "Healthcare Analytical Testing Services Market by ... Monitoring, Bioanalytical Services), by End User (Pharmaceutical Companies, ... published by MarketsandMarkets, The market witnessed healthy growth ... grow at a CAGR of 11.3% between 2016 ...
(Date:5/30/2016)... -- - DCGI grants limited approval to market Stempeucel® ... - Stempeucel® becomes 5th off-the-shelf Stem cell product to be ... - Buerger,s Disease (also known as Thromboangiitis Obliterans) is a major ... - Prevalence of Buerger,s Disease is estimated to be ... persons in the European Community & USA ...
(Date:5/27/2016)... Calif. , May 27, 2016  A new study highlights the necessity of ... by the  Journal of the American College of Radiology , a majority of oncology ... Photo - http://photos.prnewswire.com/prnh/20160527/373022 ... ... Medical Diagnostic Imaging Ampronix ...
Breaking Medicine Technology:
(Date:5/29/2016)... ... 2016 , ... "With 30 unique self-animating web themed intros and complete control ... project," said Christina Austin - CEO of Pixel Film Studios. , ProIntro Web ... in Final Cut Pro X. Pixel Film Studios’ minimalistic titles allow users to add ...
(Date:5/28/2016)... ... May 28, 2016 , ... After a year and a half of planning the ... extraordinary event. The Multiple Pathways of Recovery Conference was held May 2 -4, 2016 ... and the United Kingdom came together to explore the many pathways individuals use to get ...
(Date:5/27/2016)... ... 2016 , ... Two director-level employees of Horizon Blue Cross Blue Shield of ... 2016 honorees. The award recognizes businesswomen who excel in their fields and who ... the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ Health and Theresa ...
(Date:5/27/2016)... ... ... This campaign aims to provide a path to improved education and awareness ... change. , As nearly 795,000 Americans suffering from a new or recurrent stoke each ... an estimated 129,000 of these people dying from stroke, it’s become our nation’s fifth-leading ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses ... human interest stories, courtesy of leaders in the nursing and health care industry. ... from leading advocates and associations—namely Jones & Bartlett Learning. , Jones & Bartlett ...
Breaking Medicine News(10 mins):